Literature DB >> 10356613

[Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma].

N Gerstner1, S Wachter, D Dorner, G Goldner, A Colotto, R Pötter.   

Abstract

BACKGROUND: As known from the literature, prostate motion depends on different bladder and/or rectum fillings. The aim of this study was to analyze the influence of a rectum balloon catheter, used as an internal immobilization device, on prostate and rectum motion during the treatment course. Moreover we have analyzed if the balloon enables an increase of the distance between the prostate and the posterior rectum wall. PATIENTS AND METHODS: Ten patients with localized prostate cancer (T1 to T3) underwent computed tomographic examinations with and without rectal balloon (filled with 40 ml air) at 3 times during treatment course (at the start, middle and end of treatment). Edges of prostate, rectum and bladder were measured in relation to bony reference structures and compared for both examination series (with and without balloon).
RESULTS: An increase of the distance between the prostate and the posterior rectal wall of 8 mm was observed at the base of the prostate when using the rectum balloon (Figures 1a,b and 2). Moreover prostate motion in the ventrodorsal direction > or = 4 mm (1 SD) was reduced from 6/10 patients (60%) to 1/10 patients (10%) using the rectal balloon (Table 3, Figure 3). In general, deviations in the latero-lateral and cranio-caudal directions were less (mean < or = 2 mm, 1 SD), no difference between both examination series (with and without balloon) was observed.
CONCLUSION: Rectal balloon catheter offers a possibility to reduce prostate motion and rectum filling variations during treatment course. In addition it enables an increase in the distance between prostate and posterior rectal wall, which could enable an improved protection of the posterior rectal wall.

Entities:  

Mesh:

Year:  1999        PMID: 10356613     DOI: 10.1007/BF02742401

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  17 in total

1.  [Influence of organ and patient movements on the target volume in radiotherapy of prostatic carcinoma].

Authors:  F B Zimmermann; M Molls
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

2.  [Planned 3-dimensional low-volume conformal irradiation of a local prostatic carcinoma].

Authors:  S Wachter; N Gerstner; K Dieckmann; M Stampfer; R Hawliczek; R Pötter
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

3.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning.

Authors:  E Melian; G S Mageras; Z Fuks; S A Leibel; A Niehaus; H Lorant; M Zelefsky; B Baldwin; G J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-04-01       Impact factor: 7.038

4.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study.

Authors:  E Vigneault; J Pouliot; J Laverdière; J Roy; M Dorion
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-01       Impact factor: 7.038

5.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers.

Authors:  J M Balter; H M Sandler; K Lam; R L Bree; A S Lichter; R K ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-01       Impact factor: 7.038

6.  Analysis of prostate and seminal vesicle motion: implications for treatment planning.

Authors:  C J Beard; P Kijewski; M Bussière; R Gelman; D Gladstone; K Shaffer; M Plunkett; P Castello; C N Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-15       Impact factor: 7.038

7.  A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans.

Authors:  G S Mageras; G J Kutcher; S A Leibel; M J Zelefsky; E Melian; R Mohan; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

8.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.

Authors:  W R Lee; G E Hanks; A L Hanlon; T E Schultheiss; M A Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

9.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

Authors:  J C Roeske; J D Forman; C F Mesina; T He; C A Pelizzari; E Fontenla; S Vijayakumar; G T Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-12-01       Impact factor: 7.038

10.  Movements of the prostate due to rectal and bladder distension: implications for radiotherapy.

Authors:  S E Schild; H E Casale; L P Bellefontaine
Journal:  Med Dosim       Date:  1993       Impact factor: 1.482

View more
  6 in total

1.  Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer.

Authors:  Kenji Takayama; Takashi Mizowaki; Yoshiharu Negoro; Yoshiki Norihisa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-05       Impact factor: 3.402

2.  Assessment of accuracy and efficiency of atlas-based autosegmentation for prostate radiotherapy in a variety of clinical conditions.

Authors:  I Simmat; P Georg; D Georg; W Birkfellner; G Goldner; M Stock
Journal:  Strahlenther Onkol       Date:  2012-06-07       Impact factor: 3.621

3.  3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment.

Authors:  Gregor Goldner; Hans Geinitz; Stefan Wachter; Gerd Becker; Frank Zimmermann; Natascha Wachter-Gerstner; Stefan Glocker; Regina Pötzi; Andre Wambersie; Michael Bamberg; Michael Molls; Horst Feldmann; Richard Pötter
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

4.  Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer: a study of 2940 setup deviations in 980 MVCTs.

Authors:  Kilian Schiller; Alessia Petrucci; Hans Geinitz; Tibor Schuster; Hanno Specht; Severin Kampfer; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

5.  Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation.

Authors:  Andrea Hille; Markus K A Herrmann; Tereza Kertesz; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens-F Hess
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

6.  Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.

Authors:  Gregor Goldner; Valentin Bombosch; Hans Geinitz; Gerd Becker; Stefan Wachter; Stefan Glocker; Frank Zimmermann; Natascha Wachter-Gerstner; Andrea Schrott; Michael Bamberg; Michael Molls; Horst Feldmann; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.